In addition, a complex of Astragalus with an aluminum hydroxide adjuvant may enhance anti-breast-cancer activity by inducing an immune response to the basic fibroblast growth factor (bFGF) tumor vaccine in the TME, causing it to produce potent bFGF-specific cytotoxic T-lymphocyte activity [154]. This evidence concerns the gene FGF2 and breast carcinoma.